JUBILANT PHARMOVA
Back to Cashflow Statement
|
JUBILANT PHARMOVA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1,453 Cr | ₹-433 Cr | ₹-157 Cr | ₹-33 Cr | ₹-1,709 Cr |
What is the latest Cash Flow from Financing Activities ratio of JUBILANT PHARMOVA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1,453 Cr |
| Mar2024 | ₹-433 Cr |
| Mar2023 | ₹-157 Cr |
| Mar2022 | ₹-33 Cr |
| Mar2021 | ₹-1,709 Cr |
How is Cash Flow from Financing Activities of JUBILANT PHARMOVA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1,453 Cr | Negative | |
| Mar2024 | ₹-433 Cr | Negative | |
| Mar2023 | ₹-157 Cr | Negative | |
| Mar2022 | ₹-33 Cr | Negative | |
| Mar2021 | ₹-1,709 Cr | - | |
Compare Cash Flow from Financing Activities of peers of JUBILANT PHARMOVA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JUBILANT PHARMOVA | ₹16,001.7 Cr | -0.4% | 12.6% | 14.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,032.0 Cr | 0.9% | 12.8% | 4.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹183,759.0 Cr | 3.2% | 14% | 13.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,224.0 Cr | 0.7% | 5.5% | 36.9% | Stock Analytics | |
| CIPLA | ₹116,214.0 Cr | 6.8% | 18.8% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,739.0 Cr | 0.7% | 5.5% | 9.4% | Stock Analytics | |
JUBILANT PHARMOVA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JUBILANT PHARMOVA | -0.4% |
12.6% |
14.7% |
| SENSEX | -3.1% |
-2.8% |
-6.1% |
You may also like the below Video Courses